Cargando…

Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma

BACKGROUND: This study aimed to investigate the clinical significance of previous and/or concurrent application of radiotherapy (RT) in the course of nivolumab treatment for advanced hepatocellular carcinoma (HCC). METHODS: Patients with advanced HCC who received nivolumab treatment between March 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jeong Il, Lee, Su Jin, Lee, Jeeyun, Lim, Ho Yeong, Paik, Seung Woon, Yoo, Gyu Sang, Choi, Changhoon, Park, Hee Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853810/ https://www.ncbi.nlm.nih.gov/pubmed/31588679 http://dx.doi.org/10.1002/cam4.2570

Ejemplares similares

Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
por: Choi, Changhoon, et al.
Publicado: (2019)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2020)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2019)

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
por: Yu, Jeong Il, et al.
Publicado: (2017)

Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells
por: Choi, Changhoon, et al.
Publicado: (2021)

Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
por: Yu, Jeong Il, et al.
Publicado: (2022)

Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
por: Yu, Jeong Il, et al.
Publicado: (2016)

Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
por: Kim, Young Il, et al.
Publicado: (2012)

Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma
por: Kaya, Neslihan Arife, et al.
Publicado: (2023)

Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study
por: Yoo, Gyu Sang, et al.
Publicado: (2021)

Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
por: Yu, Jeong Il, et al.
Publicado: (2011)

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2015)

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
por: Choi, Won-Mook, et al.
Publicado: (2020)

Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Goh, Myung Ji, et al.
Publicado: (2023)

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
por: Fessas, Petros, et al.
Publicado: (2020)

Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
por: Wang, Zhiwu, et al.
Publicado: (2020)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
por: Yu, Jeong Il, et al.
Publicado: (2020)

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
por: Yu, Jeong Il, et al.
Publicado: (2017)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2021)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma
por: Ding, Yuan, et al.
Publicado: (2020)

The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2022)

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
por: Kim, Han Sang, et al.
Publicado: (2022)

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2021)

Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma
por: Seol, Seung Won, et al.
Publicado: (2015)

Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture
por: Yoo, Gyu Sang, et al.
Publicado: (2017)

Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
por: Yoo, Gyu Sang, et al.
Publicado: (2020)

Does timing matter in radiotherapy of hepatocellular carcinoma? An experimental study in mice
por: Hassan, Soha A., et al.
Publicado: (2021)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
por: Johnson, Jennifer M, et al.
Publicado: (2023)

Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
por: Yu, Jeong Il, et al.
Publicado: (2017)

Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2023)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
por: Hong, Jung Yong, et al.
Publicado: (2022)

Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
por: Yu, Jeong Il, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0ptg61p1qfn06o6cd6oa8slt5l